Dec 22 (Reuters) - AlloVir ALVR.O said on Friday it will discontinue three late-stage studies testing its lead cell therapy candidate after an independent safety board said the studies were unlikely ...

A Chinese-Swedish research team has boosted the performance of tin-lead perovskite solar cells by modifying additives and post-treatment processes. The device also demonstrated improved stability, ...

Enlivex Therapeutics is planning to advance its lead cell therapy asset, Allocetra, to Phase IIb trials following the positive results from the primary group of its Phase I/IIa study in knee ...

In a recent review published in the journal Nature, researchers collated available publications on natural killer (NK) cells – innate immune cells involved in recognizing and eliminating cells in ...